These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35264564)

  • 1. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
    Cabral-Marques O; Halpert G; Schimke LF; Ostrinski Y; Vojdani A; Baiocchi GC; Freire PP; Filgueiras IS; Zyskind I; Lattin MT; Tran F; Schreiber S; Marques AHC; Plaça DR; Fonseca DLM; Humrich JY; Müller A; Giil LM; Graßhoff H; Schumann A; Hackel A; Junker J; Meyer C; Ochs HD; Lavi YB; Scheibenbogen C; Dechend R; Jurisica I; Schulze-Forster K; Silverberg JI; Amital H; Zimmerman J; Heidecke H; Rosenberg AZ; Riemekasten G; Shoenfeld Y
    Nat Commun; 2022 Mar; 13(1):1220. PubMed ID: 35264564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    Rodriguez-Perez AI; Labandeira CM; Pedrosa MA; Valenzuela R; Suarez-Quintanilla JA; Cortes-Ayaso M; Mayán-Conesa P; Labandeira-Garcia JL
    J Autoimmun; 2021 Aug; 122():102683. PubMed ID: 34144328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
    Baiocchi GC; Vojdani A; Rosenberg AZ; Vojdani E; Halpert G; Ostrinski Y; Zyskind I; Filgueiras IS; Schimke LF; Marques AHC; Giil LM; Lavi YB; Silverberg JI; Zimmerman J; Hill DA; Thornton A; Kim M; De Vito R; Fonseca DLM; Plaça DR; Freire PP; Camara NOS; Calich VLG; Scheibenbogen C; Heidecke H; Lattin MT; Ochs HD; Riemekasten G; Amital H; Shoenfeld Y; Cabral-Marques O
    J Med Virol; 2023 Feb; 95(2):e28538. PubMed ID: 36722456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ACE2 autoantibodies after SARS-CoV-2 infection.
    Arthur JM; Forrest JC; Boehme KW; Kennedy JL; Owens S; Herzog C; Liu J; Harville TO
    PLoS One; 2021; 16(9):e0257016. PubMed ID: 34478478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis.
    Akbari A; Hadizadeh A; Islampanah M; Salavati Nik E; Atkin SL; Sahebkar A
    Autoimmun Rev; 2023 Sep; 22(9):103402. PubMed ID: 37490975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium.
    Cabral-Marques O; Moll G; Catar R; Preuß B; Bankamp L; Pecher AC; Henes J; Klein R; Kamalanathan AS; Akbarzadeh R; van Oostveen W; Hohberger B; Endres M; Koolmoes B; Levarht N; Postma R; van Duinen V; van Zonneveld AJ; de Vries-Bouwstra J; Fehres C; Tran F; do Vale FYN; da Silva Souza KB; Filgueiras IS; Schimke LF; Baiocchi GC; de Miranda GC; da Fonseca DLM; Freire PP; Hackel AM; Grasshoff H; Stähle A; Müller A; Dechend R; Yu X; Petersen F; Sotzny F; Sakmar TP; Ochs HD; Schulze-Forster K; Heidecke H; Scheibenbogen C; Shoenfeld Y; Riemekasten G
    Autoimmun Rev; 2023 May; 22(5):103310. PubMed ID: 36906052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis.
    Cabral-Marques O; Marques A; Giil LM; De Vito R; Rademacher J; Günther J; Lange T; Humrich JY; Klapa S; Schinke S; Schimke LF; Marschner G; Pitann S; Adler S; Dechend R; Müller DN; Braicu I; Sehouli J; Schulze-Forster K; Trippel T; Scheibenbogen C; Staff A; Mertens PR; Löbel M; Mastroianni J; Plattfaut C; Gieseler F; Dragun D; Engelhardt BE; Fernandez-Cabezudo MJ; Ochs HD; Al-Ramadi BK; Lamprecht P; Mueller A; Heidecke H; Riemekasten G
    Nat Commun; 2018 Dec; 9(1):5224. PubMed ID: 30523250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia.
    Xia Y; Ramin SM; Kellems RE
    Hypertension; 2007 Aug; 50(2):269-75. PubMed ID: 17576854
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms.
    Wallukat G; Hohberger B; Wenzel K; Fürst J; Schulze-Rothe S; Wallukat A; Hönicke AS; Müller J
    J Transl Autoimmun; 2021; 4():100100. PubMed ID: 33880442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-AT1R autoantibodies and prediction of the severity of Covid-19.
    Papola F; Biancofiore V; Angeletti C; Grimaldi A; Carucci AC; Cofini V; Necozione S; Rosciano A; Marinangeli F; Cervelli C
    Hum Immunol; 2022 Feb; 83(2):130-133. PubMed ID: 34772541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
    Richter AG; Shields AM; Karim A; Birch D; Faustini SE; Steadman L; Ward K; Plant T; Reynolds G; Veenith T; Cunningham AF; Drayson MT; Wraith DC
    Clin Exp Immunol; 2021 Aug; 205(2):99-105. PubMed ID: 34082475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases.
    Cabral-Marques O; Riemekasten G
    Nat Rev Rheumatol; 2017 Nov; 13(11):648-656. PubMed ID: 28855694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes.
    Moody R; Sonda S; Johnston FH; Smith KJ; Stephens N; McPherson M; Flanagan KL; Plebanski M
    Front Immunol; 2022; 13():945021. PubMed ID: 36032086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren's syndrome.
    Yue X; Deng F; Chen J; Yin J; Zheng J; Chen Y; Huang Q; Gao X; Liu Z; Luo J; Müller A; Heidecke H; Riemekasten G; Petersen F; Yu X
    Mol Immunol; 2021 Mar; 131():112-120. PubMed ID: 33446393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.
    Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G
    Front Immunol; 2018; 9():428. PubMed ID: 29623076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset IgG autoantibodies in hospitalized patients with COVID-19.
    Chang SE; Feng A; Meng W; Apostolidis SA; Mack E; Artandi M; Barman L; Bennett K; Chakraborty S; Chang I; Cheung P; Chinthrajah S; Dhingra S; Do E; Finck A; Gaano A; Geßner R; Giannini HM; Gonzalez J; Greib S; Gündisch M; Hsu AR; Kuo A; Manohar M; Mao R; Neeli I; Neubauer A; Oniyide O; Powell AE; Puri R; Renz H; Schapiro J; Weidenbacher PA; Wittman R; Ahuja N; Chung HR; Jagannathan P; James JA; Kim PS; Meyer NJ; Nadeau KC; Radic M; Robinson WH; Singh U; Wang TT; Wherry EJ; Skevaki C; Luning Prak ET; Utz PJ
    Nat Commun; 2021 Sep; 12(1):5417. PubMed ID: 34521836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG autoantibodies against ACE2 in SARS-CoV-2 infected patients.
    Hallmann E; Sikora D; Poniedziałek B; Szymański K; Kondratiuk K; Żurawski J; Brydak L; Rzymski P
    J Med Virol; 2023 Jan; 95(1):e28273. PubMed ID: 36324055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19.
    Gomes C; Zuniga M; Crotty KA; Qian K; Tovar NC; Lin LH; Argyropoulos KV; Clancy R; Izmirly P; Buyon J; Lee DC; Yasnot-Acosta MF; Li H; Cotzia P; Rodriguez A
    Life Sci Alliance; 2021 Nov; 4(11):. PubMed ID: 34504035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
    Lingel H; Meltendorf S; Billing U; Thurm C; Vogel K; Majer C; Prätsch F; Roggenbuck D; Heuft HG; Hachenberg T; Feist E; Reinhold D; Brunner-Weinzierl MC
    J Autoimmun; 2021 Aug; 122():102682. PubMed ID: 34214763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.